Thymmune Therapeutics vs Xap Therapeutics

Thymmune Therapeutics logo

Thymmune Therapeutics

Biotech firm developing thymic cell therapies to restore immune function using machine learning

26 employees · est. 2019 · Cambridge, United States

VS
Xap Therapeutics logo

Xap Therapeutics

Nature gave us the parts. We provide the blueprints

34 employees · est. 2017 · Cambridge, United Kingdom

Xap Therapeutics is the older company (2019 vs 2017).

Side-by-Side Comparison

Thymmune Therapeutics Xap Therapeutics
Founded
2019 2017 older
Headquarters
Cambridge, United States Cambridge, United Kingdom
Employees
26 34
Industry
Biotechnology, Health and Wellness Biotechnology, Health Care
Funding Stage
Seed Venture round
Total Funding
$44.30M Not tracked yet
Funding Rounds
3 1
Services
Development of thymic cell engineering platform, Mass production of iPSC-derived thymic cells, Research and development of therapies for immune disorders, Preclinical studies of thymic cell therapy, Therapeutic development for healthy immune aging Not tracked yet
Target Customers
Patients with immune-mediated diseases, Individuals with immunodeficiencies, Patients experiencing age-related immune decline, Healthcare professionals seeking innovative treatments Not tracked yet
Taxonomy
Thymic Cell TherapiesIPSC ManufacturingImmunotherapyImmune RestorationAgingDisease Treatment +7 Synthetic BiologyCell TherapeuticsCRISPR TechnologyIPSCsCell EngineeringUniversal Cell Platform +8
Website
thymmune.com xaptherapeutics.com
Thymmune Therapeutics logo

About Thymmune Therapeutics

Thymmune Therapeutics, a Cambridge, MA-based biotech firm, is pioneering in the realm of thymic cell therapies with an innovative use of machine learning to restore immune function. Founded in 2019, the company focuses on developing a unique platform that utilizes iPSC-thymic cell manufacturing to p...

Xap Therapeutics logo

About Xap Therapeutics

Xap Therapeutics (formerly known as Rockend Ltd.) is a biotechnology company based in Cambridge, UK, established in 2017. The company has garnered significant attention from well-known US/UK blue-chip VCs, with the latest Venture Round investment led by Amplitude Ventures in January 2020. Xap Thera...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Thymmune Therapeutics and Xap Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Thymmune Therapeutics or Xap Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Thymmune Therapeutics was founded in 2019, based in Cambridge, United States, with 26 employees. Thymmune Therapeutics, a Cambridge, MA-based biotech firm, is pioneering in the realm of thymic cell therapies with an innovative use of machine learning to restore immune function. Founded in 2019, t. Xap Therapeutics was founded in 2017, based in Cambridge, United Kingdom, with 34 employees. Xap Therapeutics (formerly known as Rockend Ltd.) is a biotechnology company based in Cambridge, UK, established in 2017. The company has garnered significant attention from well-known US/UK blue-chip.
Thymmune Therapeutics has raised $44.30M and Xap Therapeutics no disclosed funding. Latest stage: Thymmune Therapeutics Seed, Xap Therapeutics Venture round.
Both work in Biotechnology and list cell engineering among their focus areas.

Compare Thymmune Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Thymmune Therapeutics on 4 Mar 2026, and Xap Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes